Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience. Archives of Clinical and Biomedical Research, v. 7, n. 3, p. 325–336, 10 May2023.